Inventor · disambiguated record
Shelley Erin Ackerman
Also filed as: ACKERMAN SHELLEY · ACKERMAN SHELLEY ERIN
6 granted patents·22 pending applications·8 citations·filing 2018–2025
74Inventor score
Top patents by PatentIndex Score
28 records- 0192US11110178B2Antibody adjuvant conjugatesUNIV LELAND STANFORD JUNIOR·Filed 2020·Granted Sep 7, 2021·3 cites·30 claims
- 0291US10675358B2Antibody adjuvant conjugatesUNIV LELAND STANFORD JUNIOR·Filed 2018·Granted Jun 9, 2020·5 cites·30 claims
- 0379US12325750B2Anti-Dectin-2 antibodies and methods of usingBOLT BIOTHERAPEUTICS INC·Filed 2023·Granted Jun 10, 2025·0 cites·29 claims
- 0475US2023111340A1Antibody adjuvant conjugatesUNIV LELAND STANFORD JUNIOR·Filed 2022·Application pending·0 cites
- 0574US11547761B1Antibody adjuvant conjugatesUNIV LELAND STANFORD JUNIOR·Filed 2021·Granted Jan 10, 2023·0 cites·91 claims
- 0673US11753474B2Anti-Dectin-2 antibodiesBOLT BIOTHERAPEUTICS INC·Filed 2022·Granted Sep 12, 2023·0 cites·131 claims
- 0773US2025270329A1Anti-Dectin-2 AntibodiesBOLT BIOTHERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0868US11400164B2Immunoconjugates targeting HER2BOLT BIOTHERAPEUTICS INC·Filed 2021·Granted Aug 2, 2022·0 cites·44 claims
- 0966US2022347311A1Immunoconjugates Targeting HER2BOLT BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1061US2022195066A1Anti-cea immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1161US2025263392A1Aminobenzazepine compounds, immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1260US2025127914A1Antibody-conjugated 8-sulfonyl-benzazepine compounds and their usesBOLT BIOTHERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1358US2025145575A1Macromolecule-supported 8-sulfonyl-benzazepine compounds and their usesBOLT BIOTHERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1456US2025000995A1Tlr agonist immunoconjugates with cysteine-mutant antibodies, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1553US2024033370A1Anti-pd-l1 immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1653US2020390899A1Aminobenzazepine compounds, immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1753US2024238430A1Anti-cea immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1852US2024042050A1Anti-her2 immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1952US2024091370A1Anti-her2 immunoconjugates, and uses thereofBOLT BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2051US2023165968A1Cancer treatment methodsBOLT BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2147US2018374572A1Physical therapy, health, and wellness services coordination system and methodNue Wellness LLC·Filed 2018·Application pending·0 cites
- 2246US2022152215A1Immunoconjugates Targeting CEABOLT BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2346US2022226492A1Immunoconjugates Targeting HER2BOLT BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2446US2022226491A1Immunoconjugates Targeting PD-L1BOLT BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2546US2022143012A1Macromolecule-Supported TLR AgonistsBOLT BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2646US2021187115A1Immunoconjugates Targeting EGFRBOLT BIOTHERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2745US2021154316A1ImmunoconjugatesBOLT BIOTHERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2843US2020140556A1Methods and Compositions for Dectin-2 Stimulation and Cancer ImmunotherapyUNIV LELAND STANFORD JUNIOR·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shelley Erin Ackerman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →